Duffy Sean P. sold $587K of OMDA
Duffy Sean P. (Chief Executive Officer) sold 25,886 shares of Omada Health, Inc. (OMDA) at an average of $22.68 ($22.67–$22.70, $0.59M total) across 2 trades on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider trading record but does not introduce new fundamentals (no earnings, guidance, deal, or regulatory action).
Market read
Traders may note the insider sale for sentiment/positioning, but the 10b5-1 structure reduces the likelihood of a durable price signal.
What to watch
The article provides only the sale details; it does not state motivations, tax planning context, or whether other insiders are buying/selling around the same window.
Background
This is an SEC Form 4 disclosure of an insider open-market sale by Omada Health CEO Sean P. Duffy under a pre-arranged 10b5-1 plan.
Ticker impact
CEO Sean P. Duffy sold 25,886 shares of Omada Health on a 10b5-1 plan at about $22.685/share, totaling ~$587K.
Low near-term impact; any reaction is likely muted and short-lived.
The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and no accompanying operational or guidance change.
Market effects
No clear sector read-through; this is company-specific insider trading with no stated business catalyst.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with management de-risking ahead of volatility, so some traders may still fade strength.
Key entities
- issuerOmada Health, Inc.
Subject of the Form 4 insider sale disclosure; CEO Sean P. Duffy sold shares under a 10b5-1 plan.
- insiderSean P. Duffy
CEO and officer/director who executed the open-market sale(s).
